by Cardiovascular calcification refers to the deposition of calcium within the heart muscle or blood vessels. It is a major risk factor for cardiovascular events such as heart attack and stroke. Management of cardiovascular calcification involves identifying and monitoring calcification levels through various imaging technologies such as ultrasound, computed tomography (CT), and x-ray. It also involves slowing or reversing the progression of calcification through medications such as bisphosphonates, statins, and calcium chelators. The global cardiovascular calcification management market is driven by the growing geriatric population who are more susceptible to age-related conditions like vascular calcification.
The Global cardiovascular calcification management market is estimated to be valued at US$ 3.2 Billion in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024-2032.
Key Takeaways
Key players operating in the cardiovascular calcification management market are GE Healthcare, Philips Healthcare, Siemens Healthineers, Allena Pharmaceuticals, DBMR.
The increasing incidence of cardiovascular diseases and diabetes presents significant growth opportunities for players in the cardiovascular calcification management market. Pharmaceutical companies are investing heavily in research & development of novel therapies to treat and prevent vascular calcification.
North America dominates the global cardiovascular calcification management market due to high healthcare expenditure and presence of major market players. However, Asia Pacific is expected to witness the highest growth rate over the forecast period owing to rising healthcare standards and growing medical tourism in the region.
Market Drivers
The rising geriatric population globally is the major driver for the cardiovascular calcification management market. According to the UN, the proportion of world’s population over 60 years will nearly double from 12% to 22% between 2015 and 2050. Older adults have a higher risk of developing vascular calcification due to age-related degenerative changes in the arteries and heart valves. This has significantly increased the demand for diagnostic imaging and therapeutic management of calcific disorders.
PEST Analysis
Political: Regulatory environment for cardiovascular calcification diagnostics and therapeutics is evolving with changes in healthcare reforms. Reimbursement policies impact adoption of new treatments.
Economic: Overall healthcare spending is increasing globally. Rising incidence of cardiovascular diseases drives demand for related diagnostics and drugs despite their high cost of development and commercialization.
Social: Ageing population and lifestyle changes are major contributors to the growing cardiovascular disease burden worldwide. Greater awareness boosts screenings and improves treatment outcomes.
Technological: Advancements in imaging technologies facilitate earlier detection. Cell and gene-based therapies show promise but require further validation. Bioengineering approaches assist in elucidating disease pathways.
Geographical regions
North America leads the market owing to escalating healthcare costs associated with cardiovascular conditions. Favourable reimbursements and presence of leading industry players in the US and Canada support regional growth.
Fastest growing region
Asia Pacific exhibits fastest gains due to rising affluence, lifestyle shifts and increasing access to diagnosis and care. Rapid economic development in China and India creates conducive environment for market expansion through initiatives like ‘Make in India’ in pharmaceutical sector and rising medical tourism.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.
